David Ahn
Hoag
15 Papers
18 Citations
David Ahn is an academic researcher from Hoag. The author has contributed to research in topics: Medicine & Diabetes mellitus. The author has an hindex of 5, co-authored 12 publications. Previous affiliations of David Ahn include University of California, San Diego & University of California, Los Angeles.
Chat about Author
Papers
Continuous glucose monitoring: A review of the technology and clinical use
TL;DR: CGM is an important tool for monitoring diabetes that has been shown to improve outcomes in patients with type 1 diabetes mellitus and with appropriate patient education, CGM can also be considered for other patient populations.
241
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
David C. Klonoff,Jing Wang,David Rodbard,Michael Kohn,Chengdong Li,Dorian Liepmann,David Kerr,David Ahn,Anne L. Peters,Guillermo E. Umpierrez,Jane Jeffrie Seley,Nicole Y. Xu,Kevin T. Nguyen,Gregg D Simonson,Michael S. D. Agus,Mohammed E. Al-Sofiani,Gustavo Armaiz-Pena,Timothy L. Bailey,Ananda Basu,Tadej Battelino,Sewagegn Yeshiwas Bekele,Pierre-Yves Benhamou,B. Wayne Bequette,Thomas Blevins,Marc D. Breton,Jessica R. Castle,J. Geoffrey Chase,Kong Y. Chen,Pratik Choudhary,Mark A. Clements,Kelly L. Close,Curtiss B. Cook,Thomas Danne,Francis J. Doyle,A. Drincic,Kathleen Dungan,Steven V. Edelman,Niels Ejskjaer,Juan C. Espinoza,G. Alexander Fleming,Gregory P. Forlenza,Guido Freckmann,Rodolfo J. Galindo,Ana María Gómez,Hanna Gutow,Lutz Heinemann,Irl B. Hirsch,Thanh D. Hoang,Roman Hovorka,Johan Jendle,Li Jin,Shashank R Joshi,Michael Joubert,Suneil K. Koliwad,Rayhan A. Lal,M. Cecilia Lansang,Wei-An Andy Lee,Lalantha Leelarathna,Lawrence A. Leiter,Marcus Lind,Michelle L. Litchman,Julia K. Mader,Katherine Mahoney,Boris Mankovsky,Umesh Masharani,Nestoras Mathioudakis,Alexander Mayorov,Jordan Messler,Joshua Miller,Viswanathan Mohan,James H. Nichols,Kirsten Nørgaard,David N O'Neal,Francisco J. Pasquel,Athena Philis-Tsimikas,Thomas R. Pieber,Moshe Phillip,William H. Polonsky,Rodica Pop-Busui,Gerry Rayman,Eun-Jung Rhee,Steven Russell,Viral N. Shah,Jennifer L. Sherr,Koji Sode,Elias K. Spanakis,Deborah J Wake,Kayo Waki,Amisha Wallia,Melissa K. Weinberg,Howard Wolpert,Eugene E. Wright,Mihail Zilbermint,Boris Kovatchev +93 more
TL;DR: The GRI is a single-number summary of the quality of glycemia that provides actionable scores and a graphical display that can be used by clinicians and researchers to determine the glycemic effects of prescribed and investigational treatments.
168
How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit.
Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?
TL;DR: Findings imply that TI may be useful in helping to overcome patient resistance to insulin, improve adherence and mitigate clinical inertia in health-care providers, with potential beneficial effects on glycemic control.
17
Is There an App for That? The Pros and Cons of Diabetes Smartphone Apps and How to Integrate Them Into Clinical Practice
David Ahn,Rachel Stahl +1 more
TL;DR: Diabetes applications for electronic devices (apps) leverage the computing power and wireless connectivity of smartphones to offer unique advantages over more traditional tools such as paper logbooks and glucose meters.
11